BioScience Health Innovations, Inc.
BHIC
$4.00
-$32.04-88.90%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 97.45% | 357.44% | 342.04% | 100.99% | 198.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 97.45% | 357.44% | 342.04% | 100.99% | 198.13% |
| Cost of Revenue | 192.31% | 825.47% | 673.13% | 304.17% | 366.04% |
| Gross Profit | 64.40% | 246.17% | 281.64% | 43.34% | 164.94% |
| SG&A Expenses | 91.86% | 161.13% | 62.89% | 19.72% | 69.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 120.63% | 319.43% | 141.78% | 75.53% | 107.30% |
| Operating Income | -115.66% | 516.85% | 899.25% | 126.04% | 198.42% |
| Income Before Tax | -115.66% | 516.85% | 899.25% | 126.04% | 198.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -115.66% | 516.85% | 899.25% | 126.04% | 198.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -115.66% | 516.85% | 899.25% | 126.04% | 198.42% |
| EBIT | -115.66% | 516.85% | 899.25% | 126.04% | 198.42% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -114.81% | 487.32% | 848.08% | 123.68% | 194.74% |
| Normalized Basic EPS | -114.71% | 480.00% | 859.38% | 125.00% | 197.14% |
| EPS Diluted | -114.81% | 463.38% | 848.08% | 107.38% | 194.74% |
| Normalized Diluted EPS | -115.63% | 486.36% | 853.13% | 125.00% | 191.43% |
| Average Basic Shares Outstanding | 4.82% | 5.58% | 6.10% | 4.59% | 3.80% |
| Average Diluted Shares Outstanding | 0.78% | 5.52% | 7.11% | 8.70% | 7.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |